This Amendment No. 1 to Statement on Schedule 13D (this “Amendment”) is filed jointly by (i) Wilfried Vancraen, (ii) Hilde Ingelaere, (iii) Ailanthus NV and (iv) Idem (collectively the “Reporting Persons”) pursuant to Rule 13d-2(a) under the Securities Exchange Act of 1934, as amended. This Amendment amends and supplements the Statement on Schedule 13D (the “Schedule 13D”) originally filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on July 10, 2014 relating to the ordinary shares, no nominal value per share (the “Shares”), of Materialise NV, a limited liability company (naamloze vennootschap) organized and existing under the laws of the Kingdom of Belgium (the “Issuer”). The Schedule 13D was originally filed as a result of a recapitalization of the Issuer that occurred in connection with the closing of its initial public offering of American Depositary Shares on June 30, 2014, which recapitalization resulted in the Reporting Persons receiving certain Shares. Unless otherwise stated, information in this Amendment is provided as of November 19, 2020.
Capitalized terms used but not defined herein shall have the respective meanings set forth in the Schedule 13D.
ITEM 2. IDENTITY AND BACKGROUND
The third paragraph under Item 2 of the Schedule 13D is hereby amended and restated as follows:
Hilde Ingelaere serves Executive Vice President of the Issuer and is a Belgian citizen.
ITEM 4. PURPOSE OF TRANSACTION
The third paragraph under Item 4 of the Schedule 13D is hereby amended and restated by replacing such paragraph with the following five paragraphs:
At the request of Ailanthus NV (“Ailanthus”), of Mr. Vancraen and of Ms. Ingelaere, the board of directors of the Issuer filed on November 16, 2020 with the court registrar in Belgium a proposal to merge Ailanthus into the Issuer. The merger proposal was reviewed by the audit committee and approved by the board of directors of the Issuer, with Ms. Ingelaere, Mr. Vancraen and Sander Vancraen not participating in the deliberations. The closing of the merger is subject to the Belgian tax authorities providing a positive ruling on the tax neutrality of the transaction, which is expected to be received before year end 2020. The merger is also subject to approval by an extraordinary shareholders’ meeting of the Issuer, which is expected to take place in the last week of December 2020.
At the time of the merger, Ailanthus will have no assets or liabilities other than 13,428,688 Shares. Upon consummation of the merger, Mr. Vancraen and Ms. Ingelaere will receive, in their capacity of shareholders of Ailanthus, 13,428,688 new Shares (with the same rights and obligations as the other outstanding Shares). Immediately following the merger, the Issuer will annul the 13,428,688 Shares that it will have acquired in the merger. As a result, the same amount of Shares will be outstanding after the merger as before the transaction. Also, no other changes will be made to the organizational documents of the Issuer in connection with the merger and all existing Shares (other than the Shares formerly held by Ailanthus that will be annulled by the Issuer) will remain outstanding with the same rights that currently apply.
This transaction constitutes part of the restructuring of the family assets held by the family Vancraen-Ingelaere. Mr. Vancraen and Ms. Ingelaere have issued explicit directions that the proposed transaction should be neutral for the Issuer and its shareholders, and have agreed to compensate the Issuer for any adverse effects (including reimbursement of all expenses incurred in connection with the transaction).
The foregoing description of the terms of proposed merger is intended as a summary only and is qualified in its entirety by reference to the proposal for the merger that was filed with the court registrar in Belgium, which is filed as an exhibit to this Schedule 13D and incorporated by reference herein.